Anti-nuclear antibody, anti-DNA, and aCL in Graves' disease patients treated with propyluracil or methimazole

Lupus

Volumn 13, Issue 6, 2004, Pages 450-454

  Huang, C N ^a   Hsu, T C ^a   Chou, H H ^a   Tsay, Gregory J ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Autoantibodies; Graves' disease; Methimazole; Propylthiouracil

Indexed keywords

ANTINUCLEAR ANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; DNA ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PROPYLTHIOURACIL; THIAMAZOLE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID BINDING INHIBITORY IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; FEMALE; GOITER; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; POLYCLONAL ACTIVATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINUCLEAR; ANTITHYROID AGENTS; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAVES DISEASE; HUMANS; LOGISTIC MODELS; MALE; METHIMAZOLE; MIDDLE AGED; PROPYLTHIOURACIL;

EID: 3142714520     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203303lu1048oa     Document Type: Article

References (32)

1. Davies TF. The pathogenesis of Graves' disease. In Braverman LE, Utiger R eds. The thyroid: a fundamental and clinical text, eighth edition Philadelphia: Lippincott Williams & Wilkins, 2000: 518-531.
2. Saravanan P, Dayan CM. Thyroid autoantibodies. Endocrin Metab Clin North Am 2001; 30: 315-337.
3. Inamo Y, Harada K. Antinuclear antibody positivity in pediatric patients with autoimmune thyroid disease. J Rheumatol 1997; 24: 576-578.
4. Baethge BA, Levine SN, Wolf RE. Antibodies to nuclear antigens in Graves' disease. J Clin Endocrinol Metab 1988; 66: 485-488.
5. Hofbauer LC, Spitzweg C, Heufelder AE. Graves' disease associated with the primary antiphospholipid syndrome. J Rheumatol 1996; 23: 1435-1437.
6. Kiljanski JI, Peele K, Stachura I et al. Antibodies against striated muscle, connective tissue and nuclear antigens in patients with thyroid-associated ophthalmopathy: should Graves' disease be considered a collagen disorder? J Endocrinol Invest 1997; 20: 585-591.
7. Wartofsky L, Glinoer D, Solomon B et al. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States. Thyroid 1991; 1: 129-135.
8. Feldt-Rasmussen U, Glinoer D, Orgiazzi J. Reassessment of antithyroid drug therapy of Graves' disease. Annu Rev Med 1993; 44: 323-334.
9. Volpe R. The immunomodulatory effects of anti-thyroid drugs are mediated via actions on thyroid cells, affecting thyrocyte-immunocyte signaling: a review. Curr Pharm Des 2001; 7: 451-460.
10. Lavard L, Perrild H, Jacobsen BB, Hoier-Madsen M, Bendinelli G, Vitti P. Prevalence of thyroid peroxidase, thyroglobulin and thyrotropin receptor antibodies in a long-term follow-up ofjuvenile Graves disease. Autoimmunity 2000; 32: 167-172.
11. Loviselli A, Velluzzi F, Pala R et al. Circulating antibodies to DNA-related antigens in patients with autoimmune thyroid disorders. Autoimmunity 1992; 14: 33-36.
12. Petri M, Karlson EW, Cooper DS, Ladenson PW. Autoantibody tests in autoimmune thyroid disease: a case-control study. J Rheumatol 1991; 18: 1529-1531.
13. Tachi J, Amino N, Iwatani Y et al. Increase in antideoxyribonucleic acid antibody titer in postpartum aggravation of autoimmune thyroid disease. J Clin Endocrinol Metab 1988; 67: 1049-1053.
14. Katakura M, Yamada T, Aizawa T et al. Presence of antideoxyribo-nucleic acid antibody in patients with hyperthyroidism of Graves' disease. J Clin Endocrinol Metab 1987; 64: 405-408.
15. Morita S, Arima T, Matsuda M. Prevalence of nonthyroid specific autoantibodies in autoimmune thyroid diseases. J Clin Endocrinol Metab 1995; 80: 1203-1206.
16. Veitch J, Wilson R, Jenkins C, Thomson JA. Failure to detect anti-deoxyribonucleic acid antibody in Graves' disease in Caucasians. Autoimmunity 1989; 2: 191-194.
17. Konstadoulakis MM, Kroubouzos G, Tosca A et al. Thyroid autoantibodies in the subsets of lupus erythematosus: correlation with other autoantibodies and thyroid function. Thyroidology 1993; 5: 1-7.
18. Baker JR Jr, Miller FW, Steinberg AD, Burman KD. Thyroid stimulating and thyrotrophin binding-inhibitory immunoglobulin activity in patients with systemic lupus erythematosus having thyroid function abnormalities. Thyroid 1991; 1: 229-234.
19. Scofield RH. Autoinunune thyroid disease in systemic lupus erythematosus and Sjogren's syndrome. Clin Exp Rheumatol 1996; 14: 321-330.
20. Boey ML, Fong PH, Lee JS, Ng WY, Thai AC. Autoimmune thyroid disorders in SLE in Singapore. Lupus 1993; 2: 51-54.
21. Searles RP, Plymate SR, Troup GM. Familial thionamide-induced lupus syndrome in thyrotoxicosis. J Rheumatol 1981; 8: 498-500.
22. Takuwa N, Kojima 1, Ogata E. Lupus-like syndrome - a rare complication in thionamide treatment for Graves' disease. Endocrinol Jpn 1981; 28: 663-667.
23. Berkman EM, Orlin JB, Wolfsdorf J. An antineutrophil antibody associated with a propylthiouracil induced lupus-like syndrome. Transfusion 1983; 23: 135-138.
24. Sato-Matsumura K, Koizumi H, Matsumura T, Takahashi T, Adachi K, Ohkawara A. Lupus erythematosus-like syndrome induced by thiamazole and propylthiouracil. J Dermatol 1994; 21: 501-507.
25. Kawachi Y, Nukaga H, Hoshino M, Iwata M, Otsuka F. ANCA-associated vasculitis and lupus-like syndrome caused by methimazole. Clin Exp Dermatol 1995; 20: 345-347.
26. Yamada A, Sato K, Hara M et al. Propylthiouracil-induced lupus-like syndrome developing in a Graves' patient with a sibling with systemic lupus erythematosus. Int Medicine 2002; 41: 1204-1208.
27. Takahashi A, Tamura A, Ishikawa O. Antiphospholipid antibody syndrome complicated by Grave's disease. J Dermatol 2002; 29: 776-780.
28. Diez JJ, Dofomo RA, Iglesias P, Sastre J, Gomez-Pan A, Borbujo J. Anticardiolipin antibodies in autoimmune thyroid disease. J Clin Lab Immunol 1993; 40: 125-134.
29. Paggi A, Caccavo D, Ferri GM et al. Anti-cardiolipin antibodies in autoimmune thyroid diseases. Clin Endocrinol (Oxf) 1994; 40: 329-333.
30. 2 glycoprotein 1 than with antiphospholipid antibodies. J Rheumatol 1995; 22: 1899-1906.
31. El-Kadi HS, Keil LB, DeBari VA. Analytical and clinical relationships between human IgG autoantibodies to beta 2 glycoprotein 1 and anticardiolipin antibodies. J Rheumatol 1995; 22: 2233-2237.
32. Sanmarco M, Soler C, Christides C et al. Prevalence and clinical significance of IgG isotype anti-beta 2-glycoprotein 1 antibodies in antiphospholipid syndrome: a comparative study with anticardiolipin antibodies. J Lab Clin Med 1997; 129: 499-506.